Top Markets
Coin of the day
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Rank in Stocks #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Share Price
$10.35
Market Cap
$6.19B
Change (1 day)
3.79%
Change (1 year)
4.34%
Country
CN
Trade Gan & Lee Pharmaceuticals. (603087)

Category

Stock split history for Gan & Lee Pharmaceuticals. (603087)
Gan & Lee Pharmaceuticals. stock (symbol: 603087) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 26, 2026.
One 603087 share bought prior to Aug 26, 2026 would equal to 0 603087 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH